The common cold can protect against COVID-19: results of a new study - ForumDaily
The article has been automatically translated into English by Google Translate from Russian and has not been edited.
Переклад цього матеріалу українською мовою з російської було автоматично здійснено сервісом Google Translate, без подальшого редагування тексту.
Bu məqalə Google Translate servisi vasitəsi ilə avtomatik olaraq rus dilindən azərbaycan dilinə tərcümə olunmuşdur. Bundan sonra mətn redaktə edilməmişdir.

The common cold may protect against COVID-19: new study finds

Do some people really have the ability not to become infected with the coronavirus through contact with a sick person? Scientists at Imperial College London decided to test this theory. Voice of America.

Photo: Shutterstock

A common cold can help the body develop protection against a more dangerous virus, in particular COVID-19 - this is the conclusion reached by British scientists.

According to the co-author of the study, scientists at Imperial College London wanted to test the theory that white blood cells, the white blood cells that are produced by the average person who is infected with a cold, can protect them from COVID-19.

“Previous infections with coronaviruses, common colds—and these are distant relatives of sars-cov-2 that cause COVID—can prevent infection with the virus. Such common endemic viruses can create white blood cells that can distinguish and attack sars-cov-2. We decided to test this,” says Ajit Lalwani, a professor at Imperial College London.

On the subject: At least someone benefited from the pandemic: the top 10 richest people in the world doubled their fortunes

The research began in September 2020, before countries started vaccination programs and before infections became widespread. Scientists examined blood samples from 52 people who lived in the same house as those who fell ill with COVID-19. Half of them got infected, half didn't.

“Leukocytes, which were formed in the body due to the coronavirus, which leads to the common cold, could distinguish and attack sars-cov-2. People with such cells in their blood did not become infected,” says Lalvani.

Today's vaccines are designed in such a way that they are directed against the proteins of the outer shell of the coronavirus, which are able to mutate and bypass the immune defenses.

“In contrast, the white blood cells that we found that create this defense are directed against the proteins of the virus itself, the internal proteins. These proteins change less, so our study provides a blueprint for making a universal vaccine that induces the production of white blood cells that protect the body against current and all future strains of COVID-19,” Lalvani said.

You may be interested in: top New York news, stories of our immigrants, and helpful tips about life in the Big Apple - read it all on ForumDaily New York.

At the same time, the development of such vaccines is a matter of the distant future. Scientists say that a cold cannot be expected to provide immunity from COVID-19. The best protection against the disease is vaccination with approved drugs that have been proven safe and effective.

Read also on ForumDaily:

'The West falls into Putin's elementary trap over and over again': Alexei Navalny gave an interview to American Time

The company found rats in its factories and is now withdrawing all its products from sale

Supreme Court Blocks Biden's Mandatory Vaccination Rule: White House Accused of Abuse of Authority

Miscellanea cold World COVID-19 New vaccine
Subscribe to ForumDaily on Google News

Do you want more important and interesting news about life in the USA and immigration to America? — support us donate! Also subscribe to our page Facebook. Select the “Priority in display” option and read us first. Also, don't forget to subscribe to our РєР ° РЅР ° Р »РІ Telegram  and Instagram- there is a lot of interesting things there. And join thousands of readers ForumDaily New York — there you will find a lot of interesting and positive information about life in the metropolis. 



 
1079 requests in 1,293 seconds.